It is well known that dolphins (Latin: Delphinus) communicate with the aid of underwater acoustic signals, a concept that is at the heart of the technology being developed by Delphinus Medical Technologies. The essential scientific idea behind SoftVue is that the interaction of sound waves with cancerous tissue yields a unique signature that can be measured with our device. The manner in which sound waves travel through human tissue is governed by biomechanical tissue properties such as stiffness and density. The breast contains a wide range of tissue types, and sound waves are scattered based on their interaction with the various tissues. Conventional ultrasound records only a small fraction of the scattered field and, therefore, a small fraction of the information about the imaged tissue. The SoftVue system, on the other hand, records the entire scattered field. This additional information, ignored by conventional ultrasound imaging, results in a more accurate and complete image of the tissue characteristics. Patented algorithms, developed by Delphinus Medical Technologies, allow visualization of the inherent properties of tissue.
"SoftVue is currently under development and has not received clearance from the FDA at this time"